IDRA - Idera Pharmaceuticals EPS misses by $0.37 October, 29 2020 05:21 PM Idera Pharmaceuticals Inc. Idera Pharmaceuticals (IDRA): Q3 GAAP EPS of -$0.59 misses by $0.37.Cash, cash equivalents, and short-term investments of $28.98M.Press Release For further details see: Idera Pharmaceuticals EPS misses by $0.37